By Stanley White
TOKYO, July 21 (Reuters) - Japanese stocks rose on Tuesday as signs of progress in developing a COVID-19 vaccine boosted investor confidence in the outlook for future economic growth.
The Nikkei index was up 0.60% to 22,854.74 by 0203 GMT, with the healthcare and technology sectors leading the advance.
Initial findings from trials of three potential COVID-19 vaccines have shown encouraging results, raising hopes for a medical solution to a global pandemic that has triggered a sharp recession and caused more than half a million deaths. were 63 advancers in the Nikkei index against 157 decliners on Tuesday.
The largest percentage gainers in the index were pharmaceutical firm Daiichi Sankyo Co Ltd 4568.T up 5.09%, followed by silicon wafer maker Sumco Corp 3436.T gaining 4.61%, and Internet services firm Z Holdings Corp 4689.T up by 4.59%.
The largest percentage losses in the index were auto maker Isuzu Motors Ltd 7202.T down 3.83%, followed by Taiheiyo Cement Corp 5233.T losing 3.66%, and credit card firm Credit Saison Co Ltd 8253.T down by 3.6%.
Shares of mobile phone network operators NTT Docomo Inc 9437.T , KDDI Corp 9433.T , and Softbank Corp 0434.T dropped following a report that Japan's government is considering preventing wireless carriers from charging customers fees when they switch providers.
The broader Topix .TOPX rose 0.06% to 1,577.97.
The volume of shares traded on the Tokyo Stock Exchange's main board .TOPX was 0.53 billion, compared with the average of 1.25 billion in the past 30 days. (Editing by Sherry Jacob-Phillips)
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.